Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Conference News NY Valves 2025

Prompt TAVI Benefits Asymptomatic AS Patients Regardless of Guideline Indication

Todd Neale

June 27, 2025

News Daily News

Ataciguat Shows Potential for Curbing Progression of Aortic Stenosis

Yael L. Maxwell

February 27, 2025

News Daily News

Aortic Stenosis Slowed by SGLT2 Inhibitors in Observational Study

Yael L. Maxwell

February 20, 2025

Presentation TCT 2024

The Rise of AHA Target: Aortic Stenosis – Applying Quality Improvement Upstream of the Procedure (in partnership with the American Heart Association)

Presenter: Brian Lindman

October 30, 2024

Presentation TCT 2024

Impact of Delays in Diagnosis and Treatment: Join the AHA TARGET AS Program!

Presenter: Brian Lindman

October 30, 2024

Presentation NY Valves 2024

Impact of Delays in Diagnosis and Treatment: Introducing the TARGET AS Program

Presenter: Brian R. Lindman

June 07, 2024

Presentation TCT 2023

Pharmacotherapy to Slow AS Progression and Protect the Heart

Presenter: Brian Lindman

October 24, 2023

Presentation TCT 2023

Diagnosis to treatment of severe AS: should there be a Quality target for the US?

Presenter: Brian Lindman

October 24, 2023

Presentation TCT 2022

Access to Care in SHD Intervention: An Opportunity for Innovation?

Presenter: Brian Lindman

September 16, 2022

News Daily News

Warfarin May Speed Progression of Aortic Stenosis and Worsen Outcomes

Todd Neale

July 04, 2022

News Features

As TAVI Turns 20, How Has the Heart Team Evolved?

Yael L. Maxwell

May 04, 2022

News Daily News

LV Mass Regression After TAVR Linked to Better Long-term Outcomes

Michael O'Riordan

May 13, 2020

News Daily News

Formal Shared Decision-Making Aid for TAVR Gets Mixed Reviews

Michael O'Riordan

January 31, 2020

Presentation TVT 2019

Fix the Valve and Hope for the Best: Can We Do Better?

Presenter: Brian Lindman

June 12, 2019

Presentation The Structural Heart Disease Summit 2018

Keynote Lecture #2: Useful and Evolving Biomarkers in Aortic Stenosis and TAVR - Current Status and Future Directions

Presenter: Brian R Lindman

June 22, 2018

News Daily News

Sex Differences Diminish With Third-Generation TAVR Device

L.A. McKeown

January 05, 2018

CME

Advertisement

Prompt TAVI Benefits Asymptomatic AS Patients Regardless of Guideline Indication

Ataciguat Shows Potential for Curbing Progression of Aortic Stenosis

Aortic Stenosis Slowed by SGLT2 Inhibitors in Observational Study

The Rise of AHA Target: Aortic Stenosis – Applying Quality Improvement Upstream of the Procedure (in partnership with the American Heart Association)

Impact of Delays in Diagnosis and Treatment: Join the AHA TARGET AS Program!

Impact of Delays in Diagnosis and Treatment: Introducing the TARGET AS Program

Pharmacotherapy to Slow AS Progression and Protect the Heart

Diagnosis to treatment of severe AS: should there be a Quality target for the US?

Access to Care in SHD Intervention: An Opportunity for Innovation?

Warfarin May Speed Progression of Aortic Stenosis and Worsen Outcomes

As TAVI Turns 20, How Has the Heart Team Evolved?

LV Mass Regression After TAVR Linked to Better Long-term Outcomes

Formal Shared Decision-Making Aid for TAVR Gets Mixed Reviews

Fix the Valve and Hope for the Best: Can We Do Better?

Keynote Lecture #2: Useful and Evolving Biomarkers in Aortic Stenosis and TAVR - Current Status and Future Directions

Sex Differences Diminish With Third-Generation TAVR Device

Treatment of Severe Aortic Stenosis: Why Wait for Symptoms?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content